טוען...
Psychiatric adverse events with hydroxychloroquine during COVID-19 pandemic
• HCQ, well known in rheumatology, dermatology and tropical medicine is now considered in the treatment and prophylaxy for the SARS-CoVid19. • Mental and neurological manifestations should be assessed following the use of hydrochloroquine particularly following prophylactic use. • For acute malaria...
שמור ב:
| הוצא לאור ב: | Asian J Psychiatr |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier B.V.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7305495/ https://ncbi.nlm.nih.gov/pubmed/32603983 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajp.2020.102203 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|